Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Goldstein, E. J.
Right arrow Articles by Merriam, C. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, E. J.
Right arrow Articles by Merriam, C. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy, Vol 41, 391-396, Copyright © 1998 by The British Society for Antimicrobial Chemotherapy


ORIGINAL ARTICLES

Trovafloxacin compared with levofloxacin, ofloxacin, ciprofloxacin, azithromycin and clarithromycin against unusual aerobic and anaerobic human and animal bite-wound pathogens

EJ Goldstein, DM Citron, M Hudspeth, SH Gerardo and CV Merriam
R. M. Alden Research Laboratory, Santa Monica-UCLA Medical Center, CA 90404, USA.

The activity of trovafloxacin and five other oral agents against 250 aerobic and 137 anaerobic strains isolated from human and animal bite wounds was determined by an agar dilution method. Trovafloxacin was active against all aerobic and fastidious facultative isolates at < or = 0.5 mg/L and all anaerobes at < or = 2 mg/L (Bacteroides tectum, Porphyromonas salivosa and Prevotella heparinolytica, < or = 0.25 mg/L; Porphyromonas spp., < or = 0.5 mg/L; Prevotella spp. and peptostreptococci, < or = 2.0 mg/L), except Fusobacterium nucleatum and other fusobacteria (MIC90 < or = 4 mg/L). Levofloxacin was generally one to two dilutions more active than ofloxacin, while ciprofloxacin was active against aerobes (MIC < or = 1 mg/L) but less active against anaerobic strains (MIC90 < or = 16 mg/L).
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
P. Silley, B. Stephan, H. A. Greife, and A. Pridmore
Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats
J. Antimicrob. Chemother., November 1, 2007; 60(5): 999 - 1003.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
G. Conrads, D. M. Citron, and E. J. C. Goldstein
Genetic Determinant of Intrinsic Quinolone Resistance in Fusobacterium canifelinum
Antimicrob. Agents Chemother., January 1, 2005; 49(1): 434 - 437.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. Cercenado, S. Cercenado, and E. Bouza
In Vitro Activities of Tigecycline (GAR-936) and 12 Other Antimicrobial Agents against 90 Eikenella corrodens Clinical Isolates
Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2644 - 2645.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
E. J. C. Goldstein, D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. T. Fernandez
Comparative in vitro activity of faropenem and 11 other antimicrobial agents against 405 aerobic and anaerobic pathogens isolated from skin and soft tissue infections from animal and human bites
J. Antimicrob. Chemother., September 1, 2002; 50(3): 411 - 420.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. J. C. Goldstein, D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. T. Fernandez
In Vitro Activities of Garenoxacin (BMS-284756) against 170 Clinical Isolates of Nine Pasteurella Species
Antimicrob. Agents Chemother., September 1, 2002; 46(9): 3068 - 3070.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. J. C. Goldstein, D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. Fernandez
In Vitro Activities of a New Des-Fluoroquinolone, BMS 284756, and Seven Other Antimicrobial Agents against 151 Isolates of Eikenella corrodens
Antimicrob. Agents Chemother., April 1, 2002; 46(4): 1141 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
E. J. C. Goldstein, D. M. Citron, C. V. Merriam, Y. A. Warren, K. L. Tyrrell, and H. Fernandez
In Vitro Activities of the Des-Fluoro(6) Quinolone BMS-284756 against Aerobic and Anaerobic Pathogens Isolated from Skin and Soft Tissue Animal and Human Bite Wound Infections
Antimicrob. Agents Chemother., March 1, 2002; 46(3): 866 - 870.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
P. M. Furneri, M. Fresta, G. Puglisi, and G. Tempera
Ofloxacin-Loaded Liposomes: In Vitro Activity and Drug Accumulation in Bacteria
Antimicrob. Agents Chemother., September 1, 2000; 44(9): 2458 - 2464.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
E. J. C. Goldstein, D. M. Citron, and C. V. Merriam
Linezolid Activity Compared to Those of Selected Macrolides and Other Agents against Aerobic and Anaerobic Pathogens Isolated from Soft Tissue Bite Infections in Humans
Antimicrob. Agents Chemother., June 1, 1999; 43(6): 1469 - 1474.
[Abstract] [Full Text]


Home page
Antimicrob. Agents Chemother.Home page
E. J. C. Goldstein, D. M. Citron, C. V. Merriam, K. TyRrell, and Y. Warren
Activity of Gatifloxacin Compared to Those of Five Other Quinolones versus Aerobic and Anaerobic Isolates from Skin and Soft Tissue Samples of Human and Animal Bite Wound Infections
Antimicrob. Agents Chemother., June 1, 1999; 43(6): 1475 - 1479.
[Abstract] [Full Text]


Home page
NEJMHome page
D. A. Talan, D. M. Citron, F. M. Abrahamian, G. J. Moran, E. J.C. Goldstein, and The Emergency Medicine Animal Bite Infection Study
Bacteriologic Analysis of Infected Dog and Cat Bites
N. Engl. J. Med., January 14, 1999; 340(2): 85 - 92.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.